Stockscreener 앱 받기
4.555
0.77%
0.035
시장 영업 전:
4.56
0.005
+0.11%
전일 마감가:
$4.52
열려 있는:
$4.06
하루 거래량:
1.39M
Relative Volume:
1.23
시가총액:
$577.82M
수익:
$433.14M
순이익/손실:
$4.95M
주가수익비율:
127.59
EPS:
0.0357
순현금흐름:
$6.55M
1주 성능:
+1.00%
1개월 성능:
-1.62%
6개월 성능:
+31.65%
1년 성능:
+73.85%
1일 변동 폭
$3.58
$4.665
1주일 범위
$3.58
$4.715
52주 변동 폭
$2.28
$6.71
Organogenesis Holdings Inc Stock (ORGO) Company Profile
명칭
Organogenesis Holdings Inc
전화
781-575-0775
주소
85 DAN ROAD, CANTON, MA
ORGO을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ORGO
Organogenesis Holdings Inc
|
4.555 | 570.84M | 433.14M | 4.95M | 6.55M | 0.0357 |
|
ZTS
Zoetis Inc
|
147.35 | 64.93B | 9.39B | 2.61B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 45.07B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.54 | 41.53B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.37 | 18.37B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.50 | 13.68B | 2.99B | 1.21B | 1.13B | 25.06 |
Organogenesis Holdings Inc Stock (ORGO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-06-28 | 개시 | Lake Street | Buy |
| 2024-02-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-06-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2023-05-24 | 업그레이드 | BTIG Research | Neutral → Buy |
| 2022-11-10 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-08-10 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2020-01-10 | 개시 | SVB Leerink | Outperform |
| 2019-08-26 | 재개 | Credit Suisse | Outperform |
| 2019-05-02 | 개시 | Credit Suisse | Outperform |
| 2019-04-17 | 개시 | Oppenheimer | Outperform |
| 2019-04-11 | 개시 | SunTrust | Buy |
모두보기
Organogenesis Holdings Inc 주식(ORGO)의 최신 뉴스
Market reaction to Organogenesis Holdings Inc.’s recent newsROI Focused Setup Screener With Exit Markers - Newser
Is Organogenesis Holdings Inc. reversing from oversold territoryFree Weekly Chart Analysis With Entry Advice - Newser
How to track smart money flows in Organogenesis Holdings Inc.Free Entry and Exit Strategy Optimizer Tool - Newser
Detecting support and resistance levels for Organogenesis Holdings Inc.Free Fast Entry High Potential Stock Alerts - Newser
Organogenesis Holdings Inc. shares fall 6.64% intraday after reporting second quarter earnings. - AInvest
Transcript : Organogenesis Holdings Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Organogenesis stock price target raised to $9 by Cantor Fitzgerald - Investing.com Nigeria
Earnings call transcript: Organogenesis Q2 2025 misses EPS forecast, stock steady - Investing.com
Organogenesis: Q2 Earnings Snapshot - Connecticut Post
Organogenesis Holdings Inc (ORGO) Q2 2025 Earnings Call Highlights: Navigating Market Uncertainties Amidst Strong Growth in Surgical and Sports Medicine Products. - AInvest
Organogenesis Holdings Reports Mixed Q2 2025 Results - TipRanks
Organogenesis Holdings Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Is Organogenesis Holdings Inc. stock entering bullish territoryStock Market Trend and Pattern Analysis - Newser
Organogenesis Amends Credit Agreement Amid Revenue Decline - TipRanks
Can you recover from losses in Organogenesis Holdings Inc.Free Alert Feed for Momentum Based Picks - Newser
Applying Elliott Wave Theory to Organogenesis Holdings Inc.Free Real-Time Market Sentiment Tracking Tool - Newser
Intraday pattern recognizer results for Organogenesis Holdings Inc.Entry Optimization Guide with Volume Analysis - Newser
What technical models suggest about Organogenesis Holdings Inc.’s comebackStable Profit Zone and Loss Control Analysis - Newser
Will a bounce in Organogenesis Holdings Inc. offer an exitWatchlist Generator for Smart Money Signals - Newser
Organogenesis Holdings (NASDAQ:ORGO) Shareholders Are Still up 82% Over 1 Year Despite Pulling Back 10% in the Past Week - 富途牛牛
Analyzing drawdowns of Organogenesis Holdings Inc. with statistical toolsReal-Time Investment Signal Forecast with AI - Newser
Momentum divergence signals in Organogenesis Holdings Inc. chartFree Long Hold Safe Return Strategy - Newser
Moving Average Trends for Organogenesis Holdings Inc. Stock: What They IndicateSummary of Trade Cycles in 5-Year Range - Newser
How many analysts rate Organogenesis Holdings Inc. as a “Buy”Capitalize on market momentum for maximum profit - Jammu Links News
Is Organogenesis Holdings Inc. a growth stock or a value stockInvest smarter with cutting-edge analytics - Jammu Links News
What is Organogenesis Holdings Inc. company’s growth strategyMaximize gains with data-driven stock picks - Jammu Links News
What are analysts’ price targets for Organogenesis Holdings Inc. in the next 12 monthsConsistently superior profits - Jammu Links News
Is Organogenesis Holdings Inc. stock overvalued or undervaluedDiscover stocks with explosive upside potential - Jammu Links News
What catalysts could drive Organogenesis Holdings Inc. stock higher in 2025Exceptional risk-adjusted gains - Jammu Links News
How does Organogenesis Holdings Inc. compare to its industry peersBuild a diversified portfolio for steady growth - Jammu Links News
What institutional investors are buying Organogenesis Holdings Inc. stockOutstanding growth strategies - Jammu Links News
What makes Organogenesis Holdings Inc. stock price move sharplyDiscover stocks with strong growth potential - Jammu Links News
How Organogenesis Holdings Inc. stock performs during market volatilityFree Proven Entry Plan With Low Risk Trade - Newser
Organogenesis Holdings Inc. Stock Support and Resistance Levels You Should KnowTechnical Reversal Setup with Risk Limits - Newser
Published on: 2025-08-02 00:04:21 - Newser
Why Organogenesis Holdings Inc. stock attracts strong analyst attentionWeekly Entry Signal Based Forecast Tool - Newser
What analysts say about Organogenesis Holdings Inc. stock outlookEntry Opportunity Screener with Confirmation - Newser
Organogenesis Holdings Inc (ORGO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.43%
0.47%
자본화:
|
볼륨(24시간):